Cholangitis Market

The global cholangitis market size is estimated to register a considerable CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the growing geriatric population base. Moreover, increasing healthcare awareness among people regarding the disease and change in lifestyle are key factors anticipated to fuel the market growth.

Get Free Sample Report

When inflammation occurs due to infection in the bile duct system of an individual, it is known as cholangitis. Bile juice, which is helpful in digestion, gets carried by the bile duct also known as the biliary tract from the liver to the intestine and the gallbladder. Cholangitis happens due to a bacterial infection. The infection in the bile duct sometimes also leads to morbidity or mortality. Some of the common symptoms associated with cholangitis include fever, jaundice, abdominal pain, and low blood pressure. However, the risk of cholangitis increases to a great extent if an individual is suffering from pancreatic cancer.

It is very important to get cholangitis diagnosed and treated at the early stage as the delay can increase the chances of severe consequences. When less bile juice is secreted and the prime fat-soluble vitamins do not get absorbed into the body, it causes cholangitis. The infection, without proper precautions, can result to bile duct cancer and liver failure. Cholangitis is a very common disorder among the geriatric population base; however, it is not very common among the population under the age of 40. The effect of this disorder differs from person to person and various methods that can be used for the detection of this disorder.

Market Trends, Drivers, Restraints, and Opportunities

• Wide prevalence of disorders related to liver and increasing cases of cholangitis are anticipated to fuel the market growth during the forecast period.
• Availability of affordable healthcare diagnosis & treatment for the disorder is expected to propel the market growth during the forecast period.
• Lack of awareness of the disease treatment among the targeted population is anticipated to restrain the market growth.
• Strict regulatory policies imposed by governments for the approval of newly launched products is estimated to be a key factor that can hinder the market expansion.
• Increasing research & development activities for the development of new drugs for cholangitis is projected to create lucrative opportunities for market growth.

Scope of the Report

The report on the global cholangitis market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Market Segment Insights

Ursodeoxycholic acid segment is expected to grow at a rapid pace

On the basis of products, the global cholangitis market is segmented into ursodeoxycholic acid, obeticholic acid, and others. The ursodeoxycholic acid segment is expected to grow at a rapid pace during the forecast period owing to rising demand for the product ad increasing its usage for the treatment. The methodology used for the treatment of cholangitis depends on the condition of how severe the disease has affected the patient.

Get Free Sample Report

Endoscopic ultrasound segment is anticipated to expand at a lucrative growth rate

Based on technology, the market is divided into computed tomography, transabdominal ultrasound, magnetic resonance imaging, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, and others. The endoscopic ultrasound segment is anticipated to expand at a lucrative growth rate during the projected period attributed to its wide adoption as an alternative to percutaneous transhepatic cholangiography. The latter technology is extensively used for the second-line therapy in cases where endoscopic retrograde cholangiopancreatography fails.

Get Free Sample Report

North America is estimated to dominate the market

In terms of regions, the global cholangitis market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is estimated to dominate the market in the coming years owing to increasing awareness regarding healthcare among patients coupled with a growing geriatric population base in the region. However, the market of Asia Pacific is anticipated to grow at a considerable rate due to increasing awareness regarding the disease and rising disposable income of a large number of the regional population.

Segments

The global cholangitis market has been segmented on the basis of

Products

• Ursodeoxycholic Acid
• Obeticholic Acid
• Others

Technology

• Computed Tomography
• Transabdominal Ultrasound
• Magnetic Resonance Imaging
• Endoscopic Retrograde Cholangiopancreatography
• Endoscopic Ultrasound
• Others

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Zambon Company SPA
• Mayo Clinic
• Riemser Arzneimittel
• Gilead Sciences
• Bayer AG
• Taiho Pharmaceutical Co. Ltd.

Competitive Landscape

Key players competing in the global cholangitis market are Zambon Company SPA; Mayo Clinic; Riemser Arzneimittel; Gilead Sciences; Bayer AG; and Taiho Pharmaceutical Co. Ltd. Many of these players have adopted business strategies such as development of novel drugs, launch of new products, advancement of technologies, partnerships, mergers, and production capacity expansion in order to increase their expansion, their consumer base, and market position globally.